Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 1
1975 3
1977 1
1982 3
1983 1
1984 1
1987 1
1988 3
1989 1
1991 2
1992 2
1993 3
1994 1
1995 2
1997 6
1998 2
1999 1
2000 2
2001 2
2004 1
2005 4
2007 4
2008 2
2009 4
2010 2
2011 4
2012 5
2013 4
2014 7
2015 7
2016 8
2017 15
2018 5
2019 5
2020 4
2021 7
2022 3
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

126 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.
Howard JF Jr, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I, Jacob S, Vissing J, Burns TM, Kissel JT, Muppidi S, Nowak RJ, O'Brien F, Wang JJ, Mantegazza R; REGAIN Study Group. Howard JF Jr, et al. Lancet Neurol. 2017 Dec;16(12):976-986. doi: 10.1016/S1474-4422(17)30369-1. Epub 2017 Oct 20. Lancet Neurol. 2017. PMID: 29066163 Clinical Trial.
Long-Term Safety and Efficacy of Eculizumab in Aquaporin-4 IgG-Positive NMOSD.
Wingerchuk DM, Fujihara K, Palace J, Berthele A, Levy M, Kim HJ, Nakashima I, Oreja-Guevara C, Wang KC, Miller L, Shang S, Sabatella G, Yountz M, Pittock SJ; PREVENT Study Group. Wingerchuk DM, et al. Ann Neurol. 2021 Jun;89(6):1088-1098. doi: 10.1002/ana.26049. Epub 2021 Feb 27. Ann Neurol. 2021. PMID: 33586143 Free PMC article. Clinical Trial.
Erratum.
Matsuda S, Omoto M, Imai T, Seki K, Nomura R, Otahara Y, Yoshida T, Shima S, Kurita H, Nagaoka K, Taniwaki H, Asada Y, Shai KP, Koike M, Morita K, Watanabe Y, Mizoguchi H, Masamura K, Nagaya T, Inaba R, Sugiura H, Iwata H, Tanaka T, Ohi G, Uemura I, Akabayashi A, Kai I, Miyasaka M, Naka K. Matsuda S, et al. Among authors: omoto m. Environ Health Prev Med. 1998 Apr;3(1):63-5. doi: 10.1007/BF02931242. Environ Health Prev Med. 1998. PMID: 21432511 Free PMC article. No abstract available.
Microkeratome-assisted phacoemulsification.
Shimmura S, Omoto M, Den S, Bissen-Miyajima H, Tsubota K, Shimazaki J. Shimmura S, et al. Among authors: omoto m. J Cataract Refract Surg. 2005 Sep;31(9):1699-701. doi: 10.1016/j.jcrs.2005.02.038. J Cataract Refract Surg. 2005. PMID: 16246770
Interleukin-6 neutralization prolongs corneal allograft survival.
Kodati S, Chauhan SK, Chen Y, Emami-Naeini P, Omoto M, Dohlman TH, Stevenson W, Amouzegar A, Tummala G, Saban DR, Dana R. Kodati S, et al. Among authors: omoto m. Curr Trends Immunol. 2018;19:105-113. Curr Trends Immunol. 2018. PMID: 30906117 Free PMC article.
Keratoplasty postoperative treatment update.
Shimmura-Tomita M, Shimmura S, Satake Y, Shimazaki-Den S, Omoto M, Tsubota K, Shimazaki J. Shimmura-Tomita M, et al. Among authors: omoto m. Cornea. 2013 Nov;32 Suppl 1:S60-4. doi: 10.1097/ICO.0b013e3182a2c937. Cornea. 2013. PMID: 24104936 Clinical Trial.
126 results